Nkarta
NKTX · NASDAQ
$1.74−$0.01 (−0.57%)TodayMarket closed ·
Prev close $1.75
Who owns NKTX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 53.7% of NKTX’s shares.
- RA Capital Management, LP15.1%
- BlackRock Institutional Trust Company, N.A.6.3%
- New Enterprise Associates (NEA)5.0%
- Samsara BioCapital, LLC4.9%
- Next 6 largest institutions22.5%
- All other shareholders46.3%
| Holder | Shares | % of shares |
|---|---|---|
| RA Capital Management, LP | 10.81M | 15.10% |
| BlackRock Institutional Trust Company, N.A. | 4.47M | 6.25% |
| New Enterprise Associates (NEA) | 3.57M | 4.99% |
| Samsara BioCapital, LLC | 3.51M | 4.90% |
| SR One Capital Management, LP | 3.33M | 4.66% |
| GSK plc | 3.15M | 4.40% |
| EQT Life Sciences | 2.84M | 3.96% |
| Monaco asset management S.A.M. | 2.37M | 3.32% |
| Vanguard Capital Management, LLC | 2.23M | 3.11% |
| Citadel Advisors LLC | 2.17M | 3.04% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.57M | 2.19% |
| Wasatch Ultra Growth Fund | 1.49M | 2.08% |
| iShares Russell 2000 ETF | 1.14M | 1.59% |
| Vanguard Extended Market Index Fund | 599.53K | 0.84% |
| JPM Thematics - Genetic Therapies | 543.49K | 0.76% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $4.81K (1 trade) of NKTX on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| HASTINGS PAUL J | Sale | 1.78K | $4.81K |
| Vratsanos George | Award | 37.00K | — |
| Scheiner Zachary | Award | 37.00K | — |
| Thedinga Angela | Award | 37.00K | — |
| Behbahani Ali | Award | 37.00K | — |
| Dybbs Michael | Award | 37.00K | — |
| George Simeon | Award | 37.00K | — |
| RA Capital Healthcare Fund LP | Award | 37.00K | — |
| PATTERSON LEONE D | Award | 37.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 3.66M
- Days to cover
- 5.89
- % of shares outstanding
- 5.12%
- Average daily volume
- 621.74K
- Change since last report
- +4.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.